Peer-reviewedLicence not statedNew England Journal of Medicine22 Jul 2026

Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines

Édouard Lhomme¹
Aurélie Wiedemann²
Ahidjo Ayouba³
Safaa Ben-Farhat⁴
Guillaume Thaurignac³
Céline Roy⁴
Abdoul Habib Béavogui⁵
Seydou Doumbia⁶
Mark Kieh⁷
Bailah Leigh⁸
Samba Ousmane Sow⁹
Stephen A. Migueles¹⁰

6 more authors

Deborah Watson‐Jones¹¹
Yazdan Yazdanpanah¹²
Rodolphe Thiébaut¹
Martine Peeters³
Laura Richert¹
Yves Lévy²

12 affiliations

¹Université de Bordeaux, Bordeaux, France
²Université Paris Est Créteil, Créteil, France
³Institut de Recherche pour le Développement, Montpellier, France
⁴INSERM, Bordeaux, France
⁵Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maferinyah, Guinea
⁶University Clinical Research Center, Bamako, Mali
⁷Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia
⁸University of Sierra Leone, Freetown, Sierra Leone
⁹University of Maryland School of Medicine, Baltimore
¹⁰National Institute of Allergy and Infectious Diseases, Bethesda, MD
¹¹London School of Hygiene and Tropical Medicine, London
¹²Assistance Publique–Hôpitaux de Paris, Paris

Open at source DOI Cite

Cross-reactive antibody and functional T-cell responses to Bundibugyo virus induced by Zaire ebolavirus vaccination and infection
A. Wiedemann, A. Ayouba, E. Lhomme +8
medRxiv3 Nov 2026PreprintCC BY-NC-NDFull textInfectious diseasemedRxiv
VSV-EBOV vaccination induces cross-reactive T-cell responses against Bundibugyo virus in humans
L. Mayer, R. Londt, E. Gruener +3
medRxiv25 Sep 2026PreprintAll rights reservedFull textInfectious diseasemedRxiv
Variant-specific and cross-reactive antibody responses following COVID-19 booster vaccinations and SARS-CoV-2 breakthrough infections
Iris Medits-Weiss, Dominik Moll, David N. Springer +3
Scientific Reports1 Jul 2026Peer-reviewedCC BYFull textInfectious diseaseDOAJ
Hemagglutination-inhibition and microneutralization antibody titers as mediators of protection for cell-based and recombinant influenza vaccines
Shuyi Zhong, Wey Wen Lim, Faith Ho +7
NPJ Vaccines9 Jul 2026Peer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthPMC
Heart-reactive antibody levels differentially associate with ventricular function in hereditary cardiomyopathies
Dennis Schiffer, Boshra Afshar, Daria Grosser +12
BMC Cardiovascular Disorders25 Oct 2026Peer-reviewedCC BYFull textCardiovascular medicineDOAJ

Cite

BibTeX RIS

BibTeX

@article{lhomme2026crossreactive,
  title = {{Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines}},
  author = {Édouard Lhomme and Aurélie Wiedemann and Ahidjo Ayouba and Safaa Ben-Farhat and Guillaume Thaurignac and Céline Roy and Abdoul Habib Béavogui and Seydou Doumbia and Mark Kieh and Bailah Leigh and Samba Ousmane Sow and Stephen A. Migueles and Deborah Watson‐Jones and Yazdan Yazdanpanah and Rodolphe Thiébaut and Martine Peeters and Laura Richert and Yves Lévy},
  journal = {New England Journal of Medicine},
  year = {2026},
  month = jul,
  doi = {10.1056/nejmc2608018},
  url = {https://doi.org/10.64898/2026.05.27.26354223},
}

RIS

TY  - JOUR
TI  - Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines
AU  - Édouard Lhomme
AU  - Aurélie Wiedemann
AU  - Ahidjo Ayouba
AU  - Safaa Ben-Farhat
AU  - Guillaume Thaurignac
AU  - Céline Roy
AU  - Abdoul Habib Béavogui
AU  - Seydou Doumbia
AU  - Mark Kieh
AU  - Bailah Leigh
AU  - Samba Ousmane Sow
AU  - Stephen A. Migueles
AU  - Deborah Watson‐Jones
AU  - Yazdan Yazdanpanah
AU  - Rodolphe Thiébaut
AU  - Martine Peeters
AU  - Laura Richert
AU  - Yves Lévy
PY  - 2026
DA  - 2026/07/22
JO  - New England Journal of Medicine
DO  - 10.1056/nejmc2608018
UR  - https://doi.org/10.64898/2026.05.27.26354223
SN  - 0028-4793
SN  - 0096-6762
SN  - 1533-4406
SN  - 2331-4710
ER  -

Related

Cite